Bronchiectasis in children.
Bronchiectasis is a chronic disease of the conducting airways that produces persistent productive cough, recurrent respiratory infectious exacerbations, and obstructive lung disease in children and adults. This article focuses on the grading and recommendations for chronic therapies of bronchiectasis caused by cystic fibrosis (CF)- and non-CF-related conditions. The scope of this article is to focus on outpatient treatment and not include as-needed treatment for mild or severe pulmonary exacerbations associated with bronchiectasis.
Redding
Gregory J
GJ
Department of Pediatrics, University of Washington School of Medicine, Seattle, WA 98195-6320, USA. gredding@u.washington.edu
D000890:Anti-Infective Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001987:Bronchiectasis / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D015984:Causality; D002648:Child; D002675:Child, Preschool; D015897:Comorbidity; D003550:Cystic Fibrosis / Q000453:epidemiology; D004322:Drainage / Q000379:methods; D004334:Drug Administration Schedule; D019317:Evidence-Based Medicine; D005100:Expectorants / Q000627:therapeutic use; D006801:Humans; D009330:Nebulizers and Vaporizers; D026741:Physical Therapy Modalities
D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D005100:Expectorants